Zobrazeno 1 - 8
of 8
pro vyhledávání: '"James J Natale"'
Autor:
James J, Natale
Publikováno v:
The American journal of managed care. 24
The prevention of chemotherapy-induced nausea and vomiting (CINV) is critically important in reducing morbidity and total healthcare costs in patients receiving emetogenic chemotherapy. The different types of CINV (ie, acute, delayed, anticipatory, b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7c2bd3927e57b8c861897b0897d4cd9a
https://pubmed.ncbi.nlm.nih.gov/30328690
https://pubmed.ncbi.nlm.nih.gov/30328690
Autor:
James G. Stevenson, James J Natale
Publikováno v:
Pharmacotherapy. 27:434-446
Anemia is common in patients with cancer or myelodysplastic syndrome. Erythropoietic therapy offers an effective way to manage anemia by increasing hemoglobin levels, decreasing transfusion requirements, and alleviating symptoms. We reviewed data sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3cd3cb8802639ce77fe20aa3f72fb48
https://doi.org/10.1592/phco.27.3.434
https://doi.org/10.1592/phco.27.3.434
Autor:
James J Natale
Publikováno v:
Hospital practice (1995). 43(4)
This review provides background information on chemotherapy-induced nausea and vomiting (CINV) classification and pathophysiology and reviews various antiemetic agents for CINV prophylaxis, including corticosteroids, serotonin receptor antagonists (5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71ff0e6c38d7d7d843141bbc76cac4ba
https://pubmed.ncbi.nlm.nih.gov/26308912
https://pubmed.ncbi.nlm.nih.gov/26308912
Autor:
James J Natale, Kimia Kashef, Giorgia Rossi, David Cox, Tulla Spinelli, Selma Calcagnile, Corinna Lanzarotti
Publikováno v:
Journal of Oncology Pharmacy Practice
Neurokinin-1 (NK1) receptor antagonists (RAs) are commonly coadministered with serotonin (5-HT3) RAs (e.g. palonosetron (PALO)) to prevent chemotherapy-induced nausea/vomiting. Netupitant/palonosetron (NEPA), an oral fixed combination of netupitant (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::656a81b1668e8f46bc693f1f8417d933
https://pubmed.ncbi.nlm.nih.gov/25998320
https://pubmed.ncbi.nlm.nih.gov/25998320
Publikováno v:
Pharmacotherapy. 26:903-907
Imatinib mesylate, licensed to treat chronic myelogenous leukemia and gastrointestinal stromal tumors, is metabolized by means of cytochrome P450 3A and excreted primarily in the bile. Although the bioavailability of imatinib mesylate is more than 97
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49b8e29c41d52aac23cadbf36180ff18
https://doi.org/10.1592/phco.26.7.903
https://doi.org/10.1592/phco.26.7.903
Autor:
Kenneth A. Foon, James J Natale, T. Luong, James J. Schlesselman, Mounzer Agha, Anastasios Raptis, Michael Boyiadzis, Robert L. Redner, Wassim McHayleh, Rajesh Sehgal
Publikováno v:
Journal of Clinical Oncology. 27:7073-7073
7073 Background: The goal of induction chemotherapy in acute myeloid leukemia (AML) is complete remission with restoration of normal bone marrow. If residual leukemia is present after the first course of induction therapy, patients receive a second c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9d6460bfaf94e8c38152388142f17c9
https://doi.org/10.1200/jco.2009.27.15_suppl.7073
https://doi.org/10.1200/jco.2009.27.15_suppl.7073
Autor:
Gene Richard, Kenneth A. Foon, Ann Welsh, Wassim McHayleh, Robert L. Redner, Rajesh Sehgal, Anastasios Raptis, Michael Boyiadzis, Mounzer Agha, James J Natale
Publikováno v:
Blood. 110:4385-4385
The most effective reinduction regimen for acute myeloid leukemia (AML) patients who do not achieve complete remission (CR) after one cycle of cytarabine combined with an anthracycline is not well established. In an effort to search for new synergist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cdb3235e6ff0e031c9800cce54383d8
https://doi.org/10.1182/blood.v110.11.4385.4385
https://doi.org/10.1182/blood.v110.11.4385.4385
Autor:
McHayleh W; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15232, USA., Sehgal R, Redner RL, Raptis A, Agha M, Natale J, Luong TM, Schlesselman JJ, Foon KA, Boyiadzis M
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2009 Nov; Vol. 50 (11), pp. 1848-53.